PMA supplement
P970043 S025: LADARVISION 4000 EXCIMER LASER SYSTEM AND THE LADAR 6000 EXCIMER LASER SYSTEM
FDA PMA supplement · Normal 180 Day Track · Alcon Laboratories
Key facts
| Original PMA | P970043 |
|---|---|
| Supplement number | S025 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | LADARVISION 4000 EXCIMER LASER SYSTEM AND THE LADAR 6000 EXCIMER LASER SYSTEM |
| Generic name | Excimer laser system |
| Applicant | Alcon Laboratories |
| Product code | LZS |
| Received date | Feb 1, 2006 |
| Decision date | Jul 5, 2006 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: